Work

Efficacy and Safety of Once-Daily, Oral Iron Chelator Deferasirox (Exjade®) in a Large Group of Regularly Transfused Patients with β-Thalassemia Major

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3878.3878

Authors: Maria Domenica Cappellini, Mohsen Saleh Elalfy, Antonis Kattamis, John F Seymour, Chan Lee Lee, John B Porter, Amal El-Beshlawy, Dany Habr, Gabor Domokos, Abdel Hmissi, Ali Taher

Institutions: University of Milan, Ain Shams University, National and Kapodistrian University of Athens, Peter MacCallum Cancer Centre, University Malaya Medical Centre, University College London, Cairo University, Novartis (United States), Novartis (Switzerland), American University of Beirut

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587705773

FWCI: 0.586

Cites:

Cited by: 6

Related to: 10